Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer.

IF 4.8 Q2 ONCOLOGY
Lauren Raymond-King, Sean McGrath, Bhramar Mukherjee, Yiran Wang, Harsh Parikh, John Rothen, Pamela R Soulos, Cary P Gross, John W Kunstman
{"title":"Frailty and low utilization of curative-intent surgical resection in nonmetastatic pancreatic cancer.","authors":"Lauren Raymond-King, Sean McGrath, Bhramar Mukherjee, Yiran Wang, Harsh Parikh, John Rothen, Pamela R Soulos, Cary P Gross, John W Kunstman","doi":"10.1093/jncics/pkag078","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Curative-intent treatment for pancreatic ductal adenocarcinoma necessitates major surgery and chemotherapy, yet many patients do not undergo resection. Frailty may contribute to this phenomenon, but its prevalence and association with pancreatectomy in pancreatic ductal adenocarcinoma remains poorly defined. This study describes the distribution of frailty and its association with curative-intent surgery in a nationally representative cohort of patients with nonmetastatic pancreatic ductal adenocarcinoma.</p><p><strong>Methods: </strong>Using Surveillance, Epidemiology, and End Results-Medicare data (2013-2019), we identified patients aged 66 years and older with nonmetastatic pancreatic ductal adenocarcinoma. Frailty was categorized as nonfrail, prefrail, mildly frail, or moderately to severely frail using the claims-based frailty index over the 12 months preceding diagnosis. We evaluated frailty distributions via kernel density estimation. We assessed the association between frailty category and receipt of surgery via logistic regression.</p><p><strong>Results: </strong>Among 8237 patients (mean age = 78 years, 57.6% female, 77.4% White race), 2486 (30.2%) underwent curative-intent pancreatectomy. Surgery was performed in 39.7% of nonfrail and 30.7% of prefrail patients; after adjustment, prefrail patients had similar odds of resection compared to nonfrail patients (adjusted odds ratio [OR] = 1.01, 95% confidence interval [CI] = 0.89 to 1.16). In contrast, 15.8% of mildly frail and 5.7% of moderately to severely frail patients underwent surgery; both groups had statistically significant lower odds of surgery vs nonfrail patients (mildly frail adjusted OR = 0.53, 95% CI = 0.43 to 0.66; moderately to severely frail adjusted OR = 0.18, 95% CI = 0.11 to 0.30).</p><p><strong>Conclusions: </strong>Remarkably, less than 40% of nonfrail patients with nonmetastatic pancreatic ductal adenocarcinoma underwent surgery, suggesting that curative-intent treatment remains infrequent even among lower-risk adults. Frailty is also common and strongly associated with decreased odds of surgical resection.</p>","PeriodicalId":14681,"journal":{"name":"JNCI Cancer Spectrum","volume":" ","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2026-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13637609/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JNCI Cancer Spectrum","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/jncics/pkag078","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Curative-intent treatment for pancreatic ductal adenocarcinoma necessitates major surgery and chemotherapy, yet many patients do not undergo resection. Frailty may contribute to this phenomenon, but its prevalence and association with pancreatectomy in pancreatic ductal adenocarcinoma remains poorly defined. This study describes the distribution of frailty and its association with curative-intent surgery in a nationally representative cohort of patients with nonmetastatic pancreatic ductal adenocarcinoma.

Methods: Using Surveillance, Epidemiology, and End Results-Medicare data (2013-2019), we identified patients aged 66 years and older with nonmetastatic pancreatic ductal adenocarcinoma. Frailty was categorized as nonfrail, prefrail, mildly frail, or moderately to severely frail using the claims-based frailty index over the 12 months preceding diagnosis. We evaluated frailty distributions via kernel density estimation. We assessed the association between frailty category and receipt of surgery via logistic regression.

Results: Among 8237 patients (mean age = 78 years, 57.6% female, 77.4% White race), 2486 (30.2%) underwent curative-intent pancreatectomy. Surgery was performed in 39.7% of nonfrail and 30.7% of prefrail patients; after adjustment, prefrail patients had similar odds of resection compared to nonfrail patients (adjusted odds ratio [OR] = 1.01, 95% confidence interval [CI] = 0.89 to 1.16). In contrast, 15.8% of mildly frail and 5.7% of moderately to severely frail patients underwent surgery; both groups had statistically significant lower odds of surgery vs nonfrail patients (mildly frail adjusted OR = 0.53, 95% CI = 0.43 to 0.66; moderately to severely frail adjusted OR = 0.18, 95% CI = 0.11 to 0.30).

Conclusions: Remarkably, less than 40% of nonfrail patients with nonmetastatic pancreatic ductal adenocarcinoma underwent surgery, suggesting that curative-intent treatment remains infrequent even among lower-risk adults. Frailty is also common and strongly associated with decreased odds of surgical resection.

非转移性胰腺癌治疗意图手术切除的脆弱性和低使用率。
摘要:胰腺导管腺癌(PDAC)的治疗需要大手术和化疗,但许多患者不接受切除术。虚弱可能是导致这一现象的原因之一,但其在PDAC患者中的患病率及其与胰腺切除术的关系仍不明确。本研究描述了在全国具有代表性的非转移性PDAC患者队列中虚弱的分布及其与治疗目的手术的关系。方法:使用SEER-Medicare数据(2013-2019),我们确定了≥66岁的非转移性PDAC患者。在诊断前的12个月内,使用基于索赔的虚弱指数将虚弱分为非虚弱,虚弱前期,轻度虚弱或中度至重度虚弱。我们通过核密度估计来评估脆弱性分布。我们通过逻辑回归评估虚弱类别与接受手术之间的关系。结果:在8237例患者中(平均年龄78岁,女性57.6%,白人77.4%),2486例患者接受了治愈性胰腺切除术(30.2%)。39.7%的非体弱患者和30.7%的体弱前期患者接受了手术;调整后,体弱前期患者与非体弱患者的切除几率相似[aOR = 1.01, 95% CI =(0.89-1.16)]。相比之下,15.8%的轻度虚弱患者和5.7%的中度至重度虚弱患者接受了手术;两组患者的手术几率均显著低于非虚弱患者[轻度虚弱aOR = 0.53, 95% CI = (0.43-0.66);中度至重度虚弱[or = 0.18, 95% CI =(0.11-0.30)]。结论:值得注意的是,只有不到40%的非虚弱的非转移性PDAC患者接受了手术,这表明即使在低风险的成年人中,以治疗为目的的治疗仍然很少。虚弱也很常见,并且与手术切除的几率降低密切相关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JNCI Cancer Spectrum
JNCI Cancer Spectrum Medicine-Oncology
CiteScore
7.70
自引率
0.00%
发文量
80
审稿时长
18 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书